Phcog.Net logo
Submit

BROWSE ALL JOURNALS

    SEE ALL 6 JOURNALS
    Journal of Pharmacology and PharmacotherapeuticsNOW IN
    Article

    Risperidone-Induced Adverse Drug Reactions and Role of DRD2 (−141 C Ins/Del) and 5HTR2C (−759 C>T) Genetic Polymorphisms in Patients with Schizophrenia

    Charanraj Goud Alladi1, Anbarasan Mohan1, Deepak Gopal Shewade1★, Ravi Philip Rajkumar1, Surendiran Adithan1, Karthick Subramanian1★ Corresponding author

    1. 1Departments of Pharmacology and Psychiatry, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.

    CORRESPONDENCE

    Deepak Gopal Shewade

    Departments of Pharmacology and Psychiatry, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.

    dgshewade@gmail.com

    Received: 27-12-2016; Revised: 14-01-2017; Accepted: 20-01-2017.

    Volume 8, Issue 1 · pp. 28–32 · PUBLISHED 2017 · DOI: 10.4103/jpp.JPP_197_16

    View on J Pharmacol. Pharmacother. original site ↗

    ABSTRACT

    Objective: To determine the adverse drug reaction (ADR) profile of risperidone and their association with dopamine (DRD2 − 141 C Ins/ Del/rs1799732) and serotonin receptor (5HTR2C −759 C>T/rs3813929) gene polymorphisms in patients with schizophrenia. Materials and Methods: The study was conducted among 289 patients who were diagnosed with schizophrenia and were on treatment with risperidone (4–8 mg/day)‑based therapy for a minimum of 4 weeks. Genotyping was carried by real‑time quantitative polymerase chain reaction. All the patients were observed for the occurrences of ADRs during the study. Changes in prolactin levels and body weight were analyzed for a subgroup of 102 and 97 patients, respectively. Results: Risperidone‑induced extrapyramidal symptoms(EPSs) were seen in 36.7% of patients. Among them, tremors were the most common symptom 31.8%. Risperidone‑induced hyperprolactinemia and weight gain were seen in 87.2% and 53.6% in subgroup patients. Adverse effects such as sedation, gastrointestinal effects, and amenorrhea were seen in 9.7% (28/289), 5.1% (15/289), and 6.1% (7/114), respectively. Occurrence of DRD2 −141 Ins/Del and Del/Del polymorphisms were significantly associated with increased prolactin levels in response to risperidone (odds ratio [OR] = 10.45; 95% confidence interval = 1.29–84.89, P = 0.004). No such association was observed with 5HTR2C (−759 C>T) polymorphism. Weight gain and EPS were not associated with the above genetic polymorphisms. Conclusion: Hyperprolactinemia, weight gain, and EPSs(>36.7%) were common adverse effects of risperidone. DRD2 – 141C Ins/Del and Del/Del polymorphisms were significantly associated with increased prolactin levels (OR = 10.45) in response to risperidone.

    KEYWORDS

    Open in new tab

    REFERENCES

    As published

    Showing references and in-text citations exactly as published.

      Cite this article

      SELECT FORMAT

      Alladi, C. G., Mohan, A., Shewade, D. G., Rajkumar, R. P., Adithan, S., & Subramanian, K. (2017). Risperidone-Induced Adverse Drug Reactions and Role of DRD2 (−141 C Ins/Del) and 5HTR2C (−759 C>T) Genetic Polymorphisms in Patients with Schizophrenia. Journal of Pharmacology and Pharmacotherapeutics, 8(1), 28–32. https://doi.org/10.4103/jpp.JPP_197_16